vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and IMAX CORP (IMAX). Click either name above to swap in a different company.
IMAX CORP is the larger business by last-quarter revenue ($125.2M vs $83.5M, roughly 1.5× BillionToOne, Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs 0.5%, a 6.3% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 35.1%). IMAX CORP produced more free cash flow last quarter ($28.0M vs $6.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.
BLLN vs IMAX — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $125.2M |
| Net Profit | $5.7M | $637.0K |
| Gross Margin | 69.9% | 57.6% |
| Operating Margin | 11.5% | 19.3% |
| Net Margin | 6.8% | 0.5% |
| Revenue YoY | 117.4% | 35.1% |
| Net Profit YoY | 138.3% | -88.0% |
| EPS (diluted) | $0.10 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $125.2M | ||
| Q3 25 | $83.5M | $106.7M | ||
| Q2 25 | — | $91.7M | ||
| Q1 25 | — | $86.7M | ||
| Q4 24 | $45.1M | $92.7M | ||
| Q3 24 | $38.4M | $91.5M | ||
| Q2 24 | — | $89.0M | ||
| Q1 24 | — | $79.1M |
| Q4 25 | — | $637.0K | ||
| Q3 25 | $5.7M | $20.7M | ||
| Q2 25 | — | $11.3M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | $-11.5M | $5.3M | ||
| Q3 24 | $-14.9M | $13.9M | ||
| Q2 24 | — | $3.6M | ||
| Q1 24 | — | $3.3M |
| Q4 25 | — | 57.6% | ||
| Q3 25 | 69.9% | 63.1% | ||
| Q2 25 | — | 58.5% | ||
| Q1 25 | — | 61.4% | ||
| Q4 24 | 57.1% | 52.2% | ||
| Q3 24 | 52.6% | 55.8% | ||
| Q2 24 | — | 49.4% | ||
| Q1 24 | — | 59.3% |
| Q4 25 | — | 19.3% | ||
| Q3 25 | 11.5% | 27.2% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 19.3% | ||
| Q4 24 | 17.0% | 10.3% | ||
| Q3 24 | -32.9% | 21.2% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 15.3% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | 6.8% | 19.4% | ||
| Q2 25 | — | 12.3% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | -25.5% | 5.7% | ||
| Q3 24 | -38.8% | 15.2% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 4.1% |
| Q4 25 | — | $0.02 | ||
| Q3 25 | $0.10 | $0.37 | ||
| Q2 25 | — | $0.20 | ||
| Q1 25 | — | $0.04 | ||
| Q4 24 | $-1.13 | $0.09 | ||
| Q3 24 | $-1.47 | $0.26 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | — | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $151.2M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $337.9M |
| Total Assets | $327.5M | $894.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $151.2M | ||
| Q3 25 | $195.2M | $143.1M | ||
| Q2 25 | — | $109.3M | ||
| Q1 25 | — | $97.1M | ||
| Q4 24 | $191.5M | $100.6M | ||
| Q3 24 | — | $104.5M | ||
| Q2 24 | — | $91.6M | ||
| Q1 24 | — | $81.0M |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $51.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $337.9M | ||
| Q3 25 | $-239.5M | $349.5M | ||
| Q2 25 | — | $320.4M | ||
| Q1 25 | — | $299.5M | ||
| Q4 24 | $-251.7M | $299.5M | ||
| Q3 24 | $-242.9M | $289.4M | ||
| Q2 24 | — | $267.2M | ||
| Q1 24 | — | $258.8M |
| Q4 25 | — | $894.0M | ||
| Q3 25 | $327.5M | $889.6M | ||
| Q2 25 | — | $868.6M | ||
| Q1 25 | — | $848.3M | ||
| Q4 24 | $302.1M | $830.4M | ||
| Q3 24 | — | $847.6M | ||
| Q2 24 | — | $827.4M | ||
| Q1 24 | — | $824.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $29.4M |
| Free Cash FlowOCF − Capex | $6.5M | $28.0M |
| FCF MarginFCF / Revenue | 7.7% | 22.3% |
| Capex IntensityCapex / Revenue | 8.8% | 1.1% |
| Cash ConversionOCF / Net Profit | 2.42× | 46.11× |
| TTM Free Cash FlowTrailing 4 quarters | — | $118.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $29.4M | ||
| Q3 25 | $13.8M | $67.5M | ||
| Q2 25 | — | $23.2M | ||
| Q1 25 | — | $7.0M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | — | $35.3M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $-11.0M |
| Q4 25 | — | $28.0M | ||
| Q3 25 | $6.5M | $64.8M | ||
| Q2 25 | — | $20.9M | ||
| Q1 25 | — | $5.3M | ||
| Q4 24 | — | $6.9M | ||
| Q3 24 | — | $34.2M | ||
| Q2 24 | — | $33.5M | ||
| Q1 24 | — | $-12.1M |
| Q4 25 | — | 22.3% | ||
| Q3 25 | 7.7% | 60.7% | ||
| Q2 25 | — | 22.8% | ||
| Q1 25 | — | 6.1% | ||
| Q4 24 | — | 7.4% | ||
| Q3 24 | — | 37.3% | ||
| Q2 24 | — | 37.6% | ||
| Q1 24 | — | -15.3% |
| Q4 25 | — | 1.1% | ||
| Q3 25 | 8.8% | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 5.0% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.8% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | — | 46.11× | ||
| Q3 25 | 2.42× | 3.27× | ||
| Q2 25 | — | 2.06× | ||
| Q1 25 | — | 2.99× | ||
| Q4 24 | — | 2.16× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 9.78× | ||
| Q1 24 | — | -3.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
